c-MET signaling is frequently dysregulated and highly activated in HPV-negative HNSCC, where it drives invasion, metastasis, and epithelial-to-mesenchymal transition (EMT), a phenotype associated with resistance to cetuximab [104,107,108]. This evidence concerns the gene MET and head and neck squamous cell carcinoma.